Showing 1 - 20 results of 24 for search 'Atsunori Kashiwagi', query time: 0.06s Refine Results
  1. 1
    A new door opens, but it is essential to accumulate further clinical evidence to control heart failure in diabetes with preserved ejection fraction

    A new door opens, but it is essential to accumulate further clinical evidence to control heart failure in diabetes with preserved ejection fraction by Atsunori Kashiwagi

    Published 2019-09-01
    Get full text
    Article
  2. 2
    Stress and Vascular Responses: Oxidative Stress and Endothelial Dysfunction in the Insulin-Resistant State

    Stress and Vascular Responses: Oxidative Stress and Endothelial Dysfunction in the Insulin-Resistant State by Kazuya Shinozaki, Atsunori Kashiwagi, Masahiro Masada, Tomio Okamura

    Published 2003-01-01
    Get full text
    Article
  3. 3
    Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium‐glucose cotransporter 2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in Japan: A real‐world administrative database analysis

    Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium‐glucose cotransporter 2 inhibitors vs dipeptidyl peptidase‐4 inhibi... by Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai, Yoko Yoshinaga, Mitsuhiro Rokuda

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Malfunction of Vascular Control in Lifestyle-Related Diseases: Mechanisms Underlying Endothelial Dysfunction in the Insulin-Resistant State

    Malfunction of Vascular Control in Lifestyle-Related Diseases: Mechanisms Underlying Endothelial Dysfunction in the Insulin-Resistant State by Kazuya Shinozaki, Kazuhide Ayajiki, Atsunori Kashiwagi, Masahiro Masada, Tomio Okamura

    Published 2004-01-01
    Get full text
    Article
  5. 5
    Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world retrospective administrative database analysis in Japan

    Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibit... by Atsunori Kashiwagi, Shingo Shoji, Satoshi Onozawa, Yoshinori Kosakai, Miina Waratani, Yuichiro Ito

    Published 2022-07-01
    Get full text
    Article
  6. 6
    Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world administrative database study in Japan

    Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A... by Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai, Tadashi Koga, Keiko Asakawa, Mitsuhiro Rokuda

    Published 2023-03-01
    Get full text
    Article
  7. 7
    Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014

    Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014 by Shinji Kume, Shin‐ichi Araki, Satoshi Ugi, Katsutaro Morino, Daisuke Koya, Yoshihiko Nishio, Masakazu Haneda, Atsunori Kashiwagi, Hiroshi Maegawa

    Published 2019-07-01
    Get full text
    Article
  8. 8
    Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring

    Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring by Satoshi Ugi, Hiroshi Maegawa, Katsutaro Morino, Yoshihiko Nishio, Toshiyuki Sato, Seiki Okada, Yasuo Kikkawa, Toshihiro Watanabe, Hiromu Nakajima, Atsunori Kashiwagi

    Published 2016-07-01
    Get full text
    Article
  9. 9
    A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon‐derived peptide levels

    A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon‐derive... by Masaki Kobayashi, Nobuhiro Maruyama, Yukako Yamamoto, Takeshi Togawa, Takanori Ida, Morikatsu Yoshida, Mikiya Miyazato, Masahisa Kitada, Yoshitaka Hayashi, Atsunori Kashiwagi, Tadahiro Kitamura

    Published 2023-05-01
    Get full text
    Article
  10. 10
    Replication study for the association of 9 East Asian GWAS-derived loci with susceptibility to type 2 diabetes in a Japanese population.

    Replication study for the association of 9 East Asian GWAS-derived loci with susceptibility to type 2 diabetes in a Japanese population. by Kensuke Sakai, Minako Imamura, Yasushi Tanaka, Minoru Iwata, Hiroshi Hirose, Kohei Kaku, Hiroshi Maegawa, Hirotaka Watada, Kazuyuki Tobe, Atsunori Kashiwagi, Ryuzo Kawamori, Shiro Maeda

    Published 2013-01-01
    Get full text
    Article
  11. 11
    Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies.

    Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies. by Ren Matsuba, Minako Imamura, Yasushi Tanaka, Minoru Iwata, Hiroshi Hirose, Kohei Kaku, Hiroshi Maegawa, Hirotaka Watada, Kazuyuki Tobe, Atsunori Kashiwagi, Ryuzo Kawamori, Shiro Maeda

    Published 2016-01-01
    Get full text
    Article
  12. 12
    A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population.

    A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population. by Hisashi Fukuda, Minako Imamura, Yasushi Tanaka, Minoru Iwata, Hiroshi Hirose, Kohei Kaku, Hiroshi Maegawa, Hirotaka Watada, Kazuyuki Tobe, Atsunori Kashiwagi, Ryuzo Kawamori, Shiro Maeda

    Published 2012-01-01
    Get full text
    Article
  13. 13
    Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes.

    Replication Study in a Japanese Population to Evaluate the Association between 10 SNP Loci, Identified in European Genome-Wide Association Studies, and Type 2 Diabetes. by Ren Matsuba, Kensuke Sakai, Minako Imamura, Yasushi Tanaka, Minoru Iwata, Hiroshi Hirose, Kohei Kaku, Hiroshi Maegawa, Hirotaka Watada, Kazuyuki Tobe, Atsunori Kashiwagi, Ryuzo Kawamori, Shiro Maeda

    Published 2015-01-01
    Get full text
    Article
  14. 14
    Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?

    Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a typ... by Yukako Yamamoto, Osamu Sekine, Jun Ito‐Kobayashi, Ayane Nishida, Takeshi Togawa, Yuki Ozamoto, Yasumitsu Oe, Akeo Hagiwara, Masaki Kobayashi, Tadahiro Kitamura, Masanori Iwanishi, Akira Shimatsu, Atsunori Kashiwagi

    Published 2025-02-01
    Get full text
    Article
  15. 15
    Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese.

    Association of new loci identified in European genome-wide association studies with susceptibility to type 2 diabetes in the Japanese. by Toshihiko Ohshige, Minoru Iwata, Shintaro Omori, Yasushi Tanaka, Hiroshi Hirose, Kohei Kaku, Hiroshi Maegawa, Hirotaka Watada, Atsunori Kashiwagi, Ryuzo Kawamori, Kazuyuki Tobe, Takashi Kadowaki, Yusuke Nakamura, Shiro Maeda

    Published 2011-01-01
    Get full text
    Article
  16. 16
    The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy

    The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursion... by Yukako Yamamoto, Takeshi Togawa, Osamu Sekine, Yuki Ozamoto, Junko Fuse, Choka Azuma, Jun Ito-Kobayashi, Yasumitsu Oe, Akeo Hagiwara, Masaki Kobayashi, Tadahiro Kitamura, Masanori Iwanishi, Akira Shimatsu, Atsunori Kashiwagi

    Published 2023-12-01
    Get full text
    Article
  17. 17
    Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes.

    Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes. by Shinji Kume, Shin-ichi Araki, Nobukazu Ono, Atsuko Shinhara, Takahiko Muramatsu, Hisazumi Araki, Keiji Isshiki, Kazuki Nakamura, Hiroshi Miyano, Daisuke Koya, Masakazu Haneda, Satoshi Ugi, Hiromichi Kawai, Atsunori Kashiwagi, Takashi Uzu, Hiroshi Maegawa

    Published 2014-01-01
    Get full text
    Article
  18. 18
    Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model

    Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model by Yoichiro Kashiwagi, Shunsuke Aburaya, Naoyuki Sugiyama, Yuki Narukawa, Yuta Sakamoto, Masatomo Takahashi, Hayato Uemura, Rentaro Yamashita, Shotaro Tominaga, Satoko Hayashi, Takenori Nozaki, Satoru Yamada, Yoshihiro Izumi, Atsunori Kashiwagi, Takeshi Bamba, Yasushi Ishihama, Shinya Murakami

    Published 2021-09-01
    Get full text
    Article
  19. 19
    Author Correction: Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model

    Author Correction: Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model by Yoichiro Kashiwagi, Shunsuke Aburaya, Naoyuki Sugiyama, Yuki Narukawa, Yuta Sakamoto, Masatomo Takahashi, Hayato Uemura, Rentaro Yamashita, Shotaro Tominaga, Satoko Hayashi, Takenori Nozaki, Satoru Yamada, Yoshihiro Izumi, Atsunori Kashiwagi, Takeshi Bamba, Yasushi Ishihama, Shinya Murakami

    Published 2021-10-01
    Get full text
    Article
  20. 20
    GW501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice.

    GW501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice. by Xu Yang, Shinji Kume, Yuki Tanaka, Keiji Isshiki, Shin-ichi Araki, Masami Chin-Kanasaki, Toshiro Sugimoto, Daisuke Koya, Masakazu Haneda, Takeshi Sugaya, Detian Li, Ping Han, Yoshihiko Nishio, Atsunori Kashiwagi, Hiroshi Maegawa, Takashi Uzu

    Published 2011-01-01
    Get full text
    Article

Search Tools: